Suchergebnisse - "Meyfroidt, Geert"

PubPharm (14)

1

Returning to Elective Orthopedic Surgery During the COVID-19 Pandemic : A Multidisciplinary and Pragmatic Strategy for Initial Patient Selection

enthalten in: Journal of patient safety | 2020

von Vles, G. | Ghijselings, S. | De Ryck, I. | +5

2

Correction to : A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

enthalten in: Trials | 2020

von Devos, T. | Geukens, T. | Schauwvlieghe, A. | +22

ErratumFor: Trials. 2020 Nov 27;21(1):981. - PMID 33246499

3

Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

enthalten in: Trials | 2020

von Devos, T. | Geukens, T. | Schauwvlieghe, A. | +22

4

A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventilation : the CONFIDENT trial protocol

enthalten in: BMC pulmonary medicine | 2020

von Misset, B. | Hoste, E. | Donneau, A. | +9

ErratumIn: BMC Pulm Med. 2021 Jul 26;21(1):248. - PMID 34311718

5

A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventilation: the CONFIDENT trial protocol

enthalten in: BMC pulmonary medicine | 2020

von Misset, B. | Hoste, E. | Donneau, A. | +9

6

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19 : the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

enthalten in: Trials | 2020

von Devos, T. | Geukens, T. | Schauwvlieghe, A. | +22

ErratumIn: Trials. 2020 Dec 14;21(1):1024. - PMID 33317581

7

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

enthalten in: Trials | 2020

von Devos, T. | Geukens, T. | Schauwvlieghe, A. | +22

8

Intensive care unit acquired muscle weakness in COVID-19 patients

enthalten in: Intensive care medicine | 2020

von Van Aerde, N. | Van den Berghe, G. | Wilmer, A. | +51

9

Ensuring editorial continuity and quality of science during the COVID-19 storm : the ICM experience

enthalten in: Intensive care medicine | 2020

von Bein, T. | Vargiolu, A. | ICM Editorial Board | +19

CommentOn: J Am Osteopath Assoc. 2013 Dec;113(12):916-20. - PMID 24285034

10

Time between Symptom Onset, Hospitalisation and Recovery or Death : Statistical Analysis of Belgian COVID-19 Patients

enthalten in: International journal of environmental research and public health | 2020

von Faes, C. | Abrams, S. | Van Beckhoven, D. | +36